Search results
Novartis Singapore We invite you to learn more about Novartis and our impact on patients, families and their communities.
Novartis does not make job offers without interview and never asks candidates for money. All our current job openings are displayed here. If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.
Whether you're a customer, job seeker, health or media professional or an investor, find the best way to contact us.
Mar 15, 2024 · SINGAPORE - Swiss pharmaceutical giant Novartis is spending US$256 million (S$342.3 million) to expand its biopharmaceutical manufacturing plant here. The enlarged facility is expected to be...
Mar 15, 2024 · In 2023, Novartis’ manufacturing facilities in Singapore shipped approximately 9 million treatment doses to patients around the world suffering from chronic hives and arthritis. Singapore is committed to working with like-minded partners towards common causes.
Dec 24, 2021 · The Novartis BioProduction Operations Singapore site is their first biologics production facility in Asia and one of the largest biologics manufacturing investments in Singapore. It is aimed to launch and produce innovative biologics medicines to transform patients’ lives.
Nov 14, 2022 · BioNTech has acquired a manufacturing facility from Novartis in Singapore which it will retrofit for mRNA vaccine production.
Novartis Singapore | 11,349 followers on LinkedIn. Novartis is reimagining medicine to improve and extend people’s lives.
Since 1986, we have worked continuously to be Singapore’s trusted partner in changing the practice of medicine. Novartis Patient Declaration. The Novartis Declaration for Patients spells out our commitments in five areas, from safety to clinical trials. Download the Novartis Patient Declaration (PDF 120 KB)
Mar 15, 2024 · SWISS biopharma giant Novartis has invested US$256 million to expand its biopharmaceutical manufacturing plant in Singapore. The expanded site will focus on manufacturing therapeutic antibody drugs.
